Jan 22, 2018 by Brian FeroldiIf I Could Buy Only 1 Stock, This Would Be ItThis one company truly has it all.
Jan 22, 2018 by Brian FeroldiWhy 2017 Was a Year to Forget for Regeneron Pharmaceuticals, Inc.Find out why shareholders had to endure a roller-coaster ride to nowhere.
Jan 22, 2018 by Brian FeroldiHere's Why Community Health Systems Jumped TodayTraders cheered the news that another major investor has added to its position.
Jan 22, 2018 by Brian FeroldiWhy Array BioPharma Inc. Is SoaringEncouraging clinical data puts Wall Street in a good mood.
Jan 22, 2018 by Brian FeroldiWhy 2017 Was a Year to Remember for Ionis Pharmaceuticals, Inc.The RNA-focused biotech had a great year -- even though its share price didn't move much.
Jan 22, 2018 by Brian FeroldiJuno Therapeutics' Stock Soars on Buyout ConfirmationThe rumor turned out to be true.
Jan 21, 2018 by Brian Feroldi, Neha Chamaria, and Reuben Gregg Brewer3 Stocks That Look Just Like Google in 2004These three rocket ships look ready for takeoff.
Jan 18, 2018 by Brian FeroldiWhy Paratek Pharmaceuticals Is Sinking TodayShares dive after the antibiotic drug developer announces the pricing details of a secondary common stock offering.
Jan 17, 2018 by Brian FeroldiThis News Explains Halozyme Therapeutics' Double-Digit Drop TodayShares fall after an analyst lowers his price target. Here's what investors need to know.
Jan 17, 2018 by Brian Feroldi3 Healthcare Stocks to Buy for 2018These three healthcare gems look poised for prosperity.
Jan 14, 2018 by Brian Feroldi, Neha Chamaria, and Reuben Gregg Brewer3 High-Growth Stocks That Could SoarInvestors in these fast-growing businesses look poised for prosperity.
Jan 11, 2018 by Brian FeroldiWhy Community Health Systems Is Rising TodayA major Chinese investment firm has increased its stake in the troubled U.S. hospital operator.
Jan 10, 2018 by Brian FeroldiThis Is Why Omeros Jumped 95.8% in 2017Rising sales and upbeat clinical news have left investors feeling optimistic.
Jan 10, 2018 by Brian FeroldiWhy Appian Corp Is Rising TodayThe wild week continues for the software company.
Jan 10, 2018 by Brian FeroldiHere's Why Intuitive Surgical Vaulted 72.6% in 2017A string of guidance raises and a key regulatory win caused investors to cheer.
Jan 10, 2018 by Brian FeroldiThis Is Why Alnylam Pharmaceuticals Soared 249% in 2017It was a breakout year for the clinical-stage biotech.
Jan 9, 2018 by Brian FeroldiHere's Why TransEnterix Rallied 47% in 2017Investors can thank one big announcement for the bullish move.
Jan 9, 2018 by Brian FeroldiWhy Global Blood Therapeutics Inc Is Rising TodayTraders cheer an upbeat announcement from the FDA.
Jan 9, 2018 by Brian FeroldiHere's Why NovoCure Popped 157% in 2017 Shareholders of the cancer-focused medical device company had a year to remember.
Jan 8, 2018 by Brian FeroldiHere's Why Insulet Corporation Jumped TodayShares soar after management announced a big reimbursement win.
